Vitamin E effective, safe for fatty liver in HIV patients
(McGill University) A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a McGill-led study has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Green tea extract combined with exercise reduces fatty liver disease in mice
(Penn State) The combination of green tea extract and exercise reduced the severity of obesity-related fatty liver disease by 75% in mice fed a high-fat diet, according to Penn State researchers, whose recent study may point to a potential health strategy for people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Many Patients With NAFLD Should Be Screened for Liver Cancer, Experts Say Many Patients With NAFLD Should Be Screened for Liver Cancer, Experts Say
Screening and surveillance for hepatocellular carcinoma (HCC) is important in many patients with nonalcoholic fatty liver disease (NAFLD), according to an expert panel of the American Gastroenterological Association (AGA).Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 11, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news

Natural compound in vegetables helps fight fatty liver disease
(Texas A&M AgriLife Communications) A new study led by Texas A&M AgriLife Research scientists shows how a natural compound found in cruciferous vegetables can also be used to fight fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2020 Category: International Medicine & Public Health Source Type: news

Modifiable Risk Factors and Long-term Outcomes of NAFLD Modifiable Risk Factors and Long-term Outcomes of NAFLD
Cardiovascular disease is a leading cause of mortality in patients with non-alcoholic fatty liver disease. Can modifying CV risk factors and health behaviors improve outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Fatty Liver Disease Common Among Young Adults in the U.K.
WEDNESDAY, Jan. 29, 2020 -- One in five young adults in the United Kingdom has steatosis and one in 40 has fibrosis around the age of 24 years, according to a study published online Jan. 15 in The Lancet Gastroenterology& Hepatology. Kushala... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2020 Category: Pharmaceuticals Source Type: news

Quench Bio launches with $50M to treat 'missing link' to inflammatory disease
What do fatty liver disease, asthma and a rare genetic condition called Familial Mediterranean Fever have in common? A newly launched biotech company believes they can all be treated with one approach. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2020 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Obesity crisis blamed for a rise in fatty liver disease amongst young adults
One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today [15 January] has found. The study, published in The Lancet Gastroenterology& Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK. (Source: University of Bristol news)
Source: University of Bristol news - January 16, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, ALSPAC; Press Release Source Type: news

Obesity could be linked to a rise in fatty liver disease in young adults
One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today [15 January] has found. The study, published in The Lancet Gastroenterology& Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK. (Source: University of Bristol news)
Source: University of Bristol news - January 16, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, ALSPAC; Press Release Source Type: news

Obesity crisis blamed for a rise in fatty liver disease amongst young adults
(University of Bristol) One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today has found. The study, published in The Lancet Gastroenterology& Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2020 Category: International Medicine & Public Health Source Type: news

Curcumin: Prevent liver disease and reduce liver fat with this amazing natural plant compound
(Natural News) Fatty liver disease, also known as hepatic steatosis, is a life-threatening condition caused by an abnormal buildup of fat in the liver. While it is usually caused by excessive alcohol drinking, this disease can also stem from non-alcoholic means. This fat buildup could lead to inflammation in the liver, causing damage and creating... (Source: NaturalNews.com)
Source: NaturalNews.com - January 9, 2020 Category: Consumer Health News Source Type: news

Drug developer dips on failed psoriasis trial
Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the psoriasis study but because it also is being tested as a treatment for alcoholic hepatitis and nonalcoholic steatohepatitis, or NASH — a fatty liver disease that is one of the hottest potential commercial… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 2, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Drug developer dips on failed psoriasis trial
Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the psoriasis study but because it also is being tested as a treatment for alcoholic hepatitis and nonalcoholic steatohepatitis, or NASH — a fatty liver disease that is one of the hottest potential commercial… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 2, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
(Bar-Ilan University) SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha). 'SIRT6 is like a juggler that coordinates between metabolic processes in the body,' says the study's lead author Prof. Haim Cohen. 'By working together with PPAR-alpha, SIRT6 can actually send a message to the body to burn more fat. This cooperation is one way in which SIRT6 protects against fatty liver and fatty liver disease, as well as obesity-related damage.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2019 Category: International Medicine & Public Health Source Type: news

Gilead's NASH combination treatment fails mid-stage study
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver disease. (Source: Reuters: Health)
Source: Reuters: Health - December 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Researchers look at the ability of cordyceps to "burn" fat in the liver
(Natural News) Extracts from the medicinal mushroom Cordyceps militaris can potentially be used to prevent — even reverse — nonalcoholic fatty liver disease (NAFLD), one of the most prevalent forms of liver disease among American adults. In a study published in the Journal of Medicinal Food, researchers from South Korea investigated whether C. militaris can regulate lipogenesis in the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Taming chronic inflammation may reduce illness, save lives
Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide.The group of international experts, which also includes scientists from the National Institutes of Health, Stanford University, Harvard Medical School, Columbia University Medical Center and University College London, point to inflammation-related diseases as the cause of 50 percent of all deaths worldwide.Inflammation is a naturally occurring response by the body ’s immune system that helps fight illness and infection. Whe...
Source: UCLA Newsroom: Health Sciences - December 5, 2019 Category: Universities & Medical Training Source Type: news

Zydus Cadila files NDA for Saroglitazar Magnesium
NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatment of NASH. aroglitazar Mg has previously demonstrated improvement in both liver enzymes along with favorable effects on lipid and glycemic indices in patients with nonalcoholic fatty liver disease in Phase II clinical trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2019 Category: Pharmaceuticals Source Type: news

Tesamorelin Resolves NAFLD in Some HIV Patients Tesamorelin Resolves NAFLD in Some HIV Patients
Tesamorelin can reduce liver fat and prevent fibrosis progression in HIV patients with non-alcoholic fatty liver disease (NAFLD), according to a new phase-2 trial.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 16, 2019 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Green cardamom supplements can protect the liver for those with obesity
(Natural News) Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease today. Fatty liver is commonly caused by excessive alcohol intake. However, as its name implies, NAFLD can develop with little to no alcohol consumption. New research published in the journal BMC Complementary and Alternative Medicine suggested that people with NAFLD may benefit... (Source: NaturalNews.com)
Source: NaturalNews.com - October 29, 2019 Category: Consumer Health News Source Type: news

Researchers identify protein that can protect against non-alcoholic fatty liver disease
(Natural News) Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases in developed countries. Statistics show that about 25 percent of the world’s population suffer from this disease. As its name implies, NAFLD is not caused by excessive alcohol consumption; it is characterized by too much fat stored in liver cells. Patients with... (Source: NaturalNews.com)
Source: NaturalNews.com - October 28, 2019 Category: Consumer Health News Source Type: news

NAFLD Not Associated With Risk of Cardiovascular Disease NAFLD Not Associated With Risk of Cardiovascular Disease
Non-alcoholic fatty liver disease (NAFLD) is not associated with an increased risk of acute myocardial infarction (AMI) or stroke, according to a new cohort study in nearly 18 million Europeans.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Association Between Nut Consumption and NAFLD in Adults Association Between Nut Consumption and NAFLD in Adults
Might nut consumption be protective against development of non-alcoholic fatty liver disease?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NASH in Diabetes: New Therapies on the Horizon NASH in Diabetes: New Therapies on the Horizon
With'a host'of treatments in the pipeline, fatty liver disease no longer plays second fiddle to diabetes-related cardiovascular disease and chronic kidney disease, says researcher Gregory Nichols.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Expert Column Source Type: news

Top 34 Bestselling ‘ Fruit ’ Drinks For Kids Deemed Unhealthy
(CNN) — Americans spent $1.4 billion on the most popular brands of children’s fruit drinks and flavored waters last year. Yet according to nutritional guidelines, none of the drinks were healthy. Why would loving parents do this? Perhaps because US beverage companies spent $20.7 million to advertise fun, fruity drinks with added sugars to families in 2018, according to Children’s Drink Facts 2019, a new report from the University of Connecticut’s Rudd Center for Food Policy and Obesity. “I know that parents want their children to be healthy, but the sweetened drink market is just incredibly co...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN juice Source Type: news

Tesamorelin May Aid Patients With HIV, Fatty Liver Disease
WEDNESDAY, Oct. 16, 2019 -- Tesamorelin reduces liver fat content in patients with HIV and nonalcoholic fatty liver disease (NAFLD), according to a study published online Oct. 11 in The Lancet HIV. Takara L. Stanley, M.D., from Massachusetts General... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2019 Category: Pharmaceuticals Source Type: news

Probiotics and Prebiotics as Treatment for NAFLD Probiotics and Prebiotics as Treatment for NAFLD
This article explores different microbiota modulation strategies for the treatment of NAFLD-NASH.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Slim patients may develop Type 2 Diabetes if they don't prioritise losing fat around the middle
A new study from the University of Geneva, in Switzerland, found having a fatty liver might be another cause of type 2 diabetes because it can produce glucose on its own. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2019 Category: Consumer Health News Source Type: news

Startup with eye on fatty liver disease NASH lays out $70M IPO plan
The company started in January 2018 in Israel and moved to San Francisco this year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 14, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Startup with eye on fatty liver disease NASH lays out $70M IPO plan
The company started in January 2018 in Israel and moved to San Francisco this year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 11, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Startup with eye on fatty liver disease NASH lays out $70M IPO plan
The company started in January 2018 in Israel and moved to San Francisco this year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 11, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Fat cells are used to deliver drug that suppresses tumor growth in mice
FINDINGSIn a study with mice, researchers at the  UCLA Jonsson Comprehensive Cancer Center have identified a new mechanism for delivering a drug that can help stop tumors from growing and keep cancer from recurring. The scientists found that they could reengineer adipocytes — fat cells that provide fatty acids with the energy needed for tumors to grow and spread — to reverse their r ole in tumor development and deliver cancer-fighting drugs directly to the area of the body immediately surrounding the tumor.BACKGROUNDAlthough there have been many improvements over the past decade in treatment technique...
Source: UCLA Newsroom: Health Sciences - October 4, 2019 Category: Universities & Medical Training Source Type: news

New drug helps combat metabolic syndrome
In nonhuman trials, the drug has been shown to safely reduce plasma triglycerides and “bad” LDL cholesterol, and to reverse nonalcoholic fatty liver disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 2, 2019 Category: Universities & Medical Training Source Type: news

Study: Home-Brew in Your Gut? 'Auto-Brewery' Syndrome Linked to Fatty Liver
Title: Study: Home-Brew in Your Gut? 'Auto-Brewery' Syndrome Linked to Fatty LiverCategory: Health NewsCreated: 9/25/2019 12:00:00 AMLast Editorial Review: 9/26/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 26, 2019 Category: Nutrition Source Type: news

Can AI screen for nonalcoholic fatty liver disease?
An artificial intelligence (AI) algorithm was able to automatically quantify...Read more on AuntMinnie.comRelated Reading: Ultrasound useful for evaluating liver steatosis MRI offers view of liver fat loss in obese patients Ultrasound options abound for diagnosing liver disease AIUM: Can deep learning classify liver fibrosis on US? Fatty liver disease occurs with risky plaque (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 20, 2019 Category: Radiology Source Type: news

Gut Microbe Linked to Nonalcoholic Fatty Liver Disease
Researchers find strains of the bacterium Klebsiella pneumoniae that produce high levels of alcohol in 60 percent of patients with the condition. (Source: The Scientist)
Source: The Scientist - September 19, 2019 Category: Science Tags: News & Opinion Source Type: news

Medical News Today: Gut bacteria may damage liver by turning carbs into alcohol
Researchers find strains of gut bacteria that turn carbohydrates into alcohol. This may contribute to nonalcoholic fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 19, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Former Brexit MP DAVID DAVIS reveals the low-carb diet that helped transform his health 
DAVID DAVIS:A year ago, after I resigned from my Cabinet job as Brexit Secretary, I had a routine medical. The doctor frowned, I had non-alcoholic fatty liver disease (NAFLD). (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news

Weight-Loss Surgery Dramatically Lowers the Risk of Early Death, a New Study Finds
For decades, doctors have known that losing weight can significantly lower risk of heart disease and by extension, reduce the risk of dying from heart-related events such as stroke and heart attack. Studies have shown that both lifestyle changes including diet and exercise as well as medications and weight-loss surgery can improve heart disease risk factors such as obesity and diabetes, for example, but data supporting the benefits of any of these approaches in actually lowering rates of heart events such as heart attack and atrial fibrillation, or in reducing early deaths from heart disease, have been less robust. The dat...
Source: TIME: Health - September 2, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized diabetes Heart Disease Source Type: news

Mixed Outcomes After Liver Resection for NAFLD-Associated Cancer Mixed Outcomes After Liver Resection for NAFLD-Associated Cancer
Liver resection for nonalcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC) is associated with favorable long-term survival but with more surgical morbidity and post-hepatectomy liver failure, compared with non-NAFLD HCC, researchers from Singapore report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 28, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Fatty Liver or Visceral Fat and Insulin Resistance Fatty Liver or Visceral Fat and Insulin Resistance
Findings from a new study suggest that fatty liver may be a better marker than visceral fat accumulation for predicting insulin resistance.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Supplementation with myo-inositol found to decrease triglyceride buildup in fructose-induced fatty liver
In this study, researchers from Gifu University in Japan investigated the effects of myo-inositol supplementation on fatty liver induced by fructose intake instead of sucrose. The results of their study were published in the journal of Nutrition Research. Excessive fructose ingestion drastically increases the accumulation of fat in the liver. According to previous... (Source: NaturalNews.com)
Source: NaturalNews.com - August 14, 2019 Category: Consumer Health News Source Type: news

Curcumin improves symptoms of NAFLD and obesity
(Natural News) Consuming large amounts of curcumin — the bioactive compound present in the spice turmeric — may help improve obesity and non-alcoholic fatty liver disease (NAFLD) in patients with both. An Iranian study found that taking curcumin supplements decreases factors that contribute to the two health conditions. The researchers compared the effects of a curcumin... (Source: NaturalNews.com)
Source: NaturalNews.com - August 13, 2019 Category: Consumer Health News Source Type: news

Barley sprouts can help address fatty liver disease, says study
(Natural News) Cholesterol is a wax-like, fat-like molecule produced by the body and obtained from food. Its main functions are as a building material for cell membranes and as a component in the production of certain hormones and compounds that aid in fat digestion. However, high amounts of cholesterol in the blood lead to the... (Source: NaturalNews.com)
Source: NaturalNews.com - August 13, 2019 Category: Consumer Health News Source Type: news

Prescription of Statins in Suspected NAFLD and High CVD Risk Prescription of Statins in Suspected NAFLD and High CVD Risk
Might most patients with suspected non-alcoholic fatty liver disease benefit from statin therapy?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Potential new treatment for non-alcoholic fatty liver disease
Clinical trials in Germany and Austria for a new NAFLD treatment have shown success, according to a report inThe Lancet Gastroenterology& Hepatology.Medical News Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 1, 2019 Category: Endocrinology Source Type: news

Is Sugar as Bad for Kids as It Is for Adults?
Kids love sweets. Of course, so do many adults. But even those grown-ups with a serious sweet tooth would likely struggle to polish off a big bag of candy, while the average kid would relish that chore. “Even during infancy, newborns have an innate preference for breast milk because of its sweetness,” says Juliana Cohen, an assistant professor of nutrition at Merrimack College in Northern Massachusetts and the Harvard School of Public Health. Cohen says the prevailing theory is that a taste for sugary foods offered early humans an evolutionary advantage: In nature, sweet foods—stuff like fruits or honey&m...
Source: TIME: Health - August 1, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Source Type: news

Your liver loves schisandra extract: Research shows these berries reduce risk of NAFLD, liver dysfunction
(Natural News) The berries of Schisandra sphenanthera displayed protective effects on the liver. Chinese researchers showed that an extract made from the dried fruit could delay the progression of non-alcoholic fatty liver disease. A cousin to the five-flavor fruit (Schisandra chinensis) favored by natural health practitioners, S. sphenanthera is also extensively used in China. Its fruits undergo drying and extraction processes to... (Source: NaturalNews.com)
Source: NaturalNews.com - July 30, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Nonalcoholic fatty liver disease: New drug proves 'safe' and effective
A double-blind, placebo-controlled randomized clinical trial finds the right dosage at which a drug 'safely' treats nonalcoholic fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 30, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

The Downside of Having a Sweet Tooth
Regular consumption of sugary drinks heightens the risk not only of tooth decay, obesity, fatty liver disease and Type 2 diabetes, but also of heart disease and premature death. (Source: NYT Health)
Source: NYT Health - July 22, 2019 Category: Consumer Health News Authors: Jane E. Brody Tags: Sugar Obesity Diet and Nutrition Artificial Sweeteners Diabetes Corn Syrup and Sweeteners Source Type: news